With transparent disclosure of information and communication with markets,
we will grow along with shareholders.
Corporate Governance Structure
||Seung-kook Park, Seung-won Jeong
||November 20th 1973
||December 18th 1989 (listed on KOSPI)
||Daewoong Pharmaceutical Co., Ltd.
||26.1 billion KRW
|Total Issued shares
|Number of Employees
||309 (As of Dec.31, 2020)
Board of Directors
||Chariman, Board of Directors; Chief Executive Officer, Daewoong Pharmaceutical
|Seung-kook Park, Ph.D.
||President & Chief Executive Officer; Former Head of R&D, Daewoong Pharmaceutical
|Sean (Seungwon) Jeong, M.D., MBA
||President & Chief Executive Officer; Former Head of Bone Japan/China, UCB; Former New Products Director, Novartis
||Chief Financial Officer
||Independent Director; Accountant, Samdo Accounting Firm Partner+K37
||Independent Director; Founder & Chief Executive Officer, Bridge Biotherapeutics
|Hun Jung, M.D., Ph.D.
||Independent Director; Founder & Chief Executive Officer, Aston Science